Compare NCEL & MSGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NCEL | MSGM |
|---|---|---|
| Founded | 2008 | 2018 |
| Country | Switzerland | United States |
| Employees | 4 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.0M | 19.0M |
| IPO Year | N/A | 2020 |
| Metric | NCEL | MSGM |
|---|---|---|
| Price | $3.42 | $4.73 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 24.8K | 18.5K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 252.13 |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $741,000.00 |
| Revenue This Year | N/A | $69.73 |
| Revenue Next Year | N/A | $146.81 |
| P/E Ratio | ★ N/A | $72.17 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.83 | $2.11 |
| 52 Week High | $5.12 | $5.78 |
| Indicator | NCEL | MSGM |
|---|---|---|
| Relative Strength Index (RSI) | 46.05 | 55.15 |
| Support Level | $2.95 | $3.71 |
| Resistance Level | $3.62 | $4.93 |
| Average True Range (ATR) | 0.29 | 0.31 |
| MACD | -0.07 | -0.01 |
| Stochastic Oscillator | 40.59 | 65.71 |
NewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional insulin production through scalable, off-the-shelf cell replacement. It is advancing a comprehensive therapeutic approach for Type 1 Diabetes, integrating cell therapy, immune protection, and translational science, including a phase IIa clinical trial for the treatment of Amyotrophic Lateral Sclerosis (ALS) in the field of regenerative medicine, as well as the development of treatments for Central Nervous System (CNS) disorders, including Narcolepsy, utilizing its Doxa platform. Its products are Holistic, IsletRx, AstroRx, and the DOXA platform.
Motorsport Games Inc is a racing game developer, publisher, and esports ecosystem provider of official motorsport racing series, including games based on the 24 Hours of Le Mans endurance race (Le Mans) and the associated FIA World Endurance Championship (the WEC). Its portfolio also includes the KartKraft karting simulation game, as well as Studio 397 B.V. (Studio397) and their rFactor 2 realistic racing simulator technology and platform. The games are developed and published for personal computers (PCs) through various digital channels, including full-game and downloadable content (DLC). Additionally, Motorsport Games organizes esports tournaments, competitions, and events. Its reportable segments are: Gaming, which generates the maximum revenue, and Esports.